NovaBay Pharmaceuticals, Inc. (NYSE:NBY) is among the 15 Best Biotech Penny Stocks to Invest in Right Now, specializing in anti-infective therapies with products like Avenova. In September 2025, the company declared a $0.80 special dividend per share, showcasing strong financial stability and commitment to shareholder value.

Despite no new product launches, NovaBay Pharmaceuticals, Inc. (NYSE:NBY) focuses on its antimicrobial and eye care portfolio, maintaining market performance. The special dividend and upcoming annual meeting signal potential profitability and strong cash flow, making it an attractive biotech penny stock for investors seeking long-term value.

Investors considering NBY should note that some AI stocks may offer greater upside potential and lower risk. For those interested in undervalued AI stocks benefiting from current economic trends, a free report on the best short-term AI stock is available.

Disclosure: None.

Read more at Yahoo Finance: NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value